XTLB
XTL Biopharmaceuticals
XTLB
XTLB
6 hedge funds and large institutions have $2.14M invested in XTL Biopharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$56K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$13K |
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$98K |
| 2 |
SW
2
SteelPeak Wealth
Woodland Hills,
California
|
$0 |
| 3 |
3
Morgan Stanley
New York
|
$226K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NC
1
Noked Capital
Tel Aviv,
Israel
| $871K | 198,888 | – | – |
|
|
NI
2
Noked Israel
Ramat Hasharon,
Israel
| $871K | 198,888 | – | – |
|
|
3
Morgan Stanley
New York
| $226K | 51,671 | -2,393 | -4% |
|
|
4
Renaissance Technologies
New York
| $98K | 22,280 | -14,907 | -40% |
|
|
5
Citadel Advisors
Miami,
Florida
| $56K | 12,801 | +12,801 | New |
|
|
6
UBS Group
Zurich,
Switzerland
| $13K | 2,898 | +2,898 | New |
|
|
SW
7
SteelPeak Wealth
Woodland Hills,
California
| – | – | -11,671 | Closed |
|
|
CFGS
8
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|